future of protein production with plates with healthy food and protein

Meatable strengthens Board of Directors to accelerate growth of breakthrough food technology

February 16, 2024

Meatable has announced the appointments of Lorne Abony and Patricia Malarkey to the company’s Board of Directors. The appointments of USA-based Abony and Malarkey add to the diversity and expertise guiding the company’s efforts to efficiently and sustainably improve the world’s food supply chain.

“We are thrilled to welcome Lorne and Trish, whose careers have established them as key innovators and leaders across a wide array of verticals throughout the finance and food ecosystem, to the Meatable team,” commented Krijn de Nood, Co-founder & CEO at Meatable. “Meatable is at an exciting juncture in our growth trajectory as we prepare to launch our consumer products in Singapore and host our first tasting in the EU. We look forward to tapping into the strategic industry expertise that Lorne and Trish add to our Board to help guide us through this next stage in our commercialization roadmap. Following a successful launch in Singapore, our team is looking forward to bringing our delicious and environmentally sustainable meat products to the USA. We are confident Lorne and Trish will help accelerate and enhance our efforts to effectively enter this important market.”

Abony is a well-known USA-based entrepreneur whose many successful ventures include the 2001 founding of FUN Technologies, which he sold in 2006 to Liberty Media for US$484 million. He was the founding shareholder and Executive Chairman of wellness player Emmac, which was sold in 2021 to Curaleaf for US$407 million. Prior to Emmac, Abony was the CEO and founder of NuuVera, a Canadian wellness organization listed on the TSX, which was sold to Aphria in 2018 for CA$826 million. Prior to NuuVera, Abony was the founder and CEO of Mood Media Corporation, the world’s largest in-store media company. Abony has significant capital markets experience having raised more than US$1.7 billion through the public and private debt and equity markets. On the Meatable Board, he will support the company’s management team by advising on commercial development initiatives in the USA as well as future transactions.

“The Meatable vision is extremely compelling, as is their leadership in producing high-quality, delicious meat cost-effectively and at unprecedented speed,” said Abony. “Compared to others in its category, Meatable is highly differentiated through its industry-first technology and phased approach. I look forward to contributing to Meatable’s growth journey as the company continues to execute on its methodical and transparent strategy of product development and commercialization that has led to the development of proven technology and industrial processes.”

Abony serves as a Board member for several companies, including Pluri, VitroLabs, Enride and Voxia. He earned his MBA from Columbia Business School, his J.D. from the University of Windsor, and his Bachelor’s degree from McGill University.

Patricia ('Trish') Malarkey brings more than 30 years of experience in executive and non-executive roles in science and innovation for leading food and agtech companies. She has developed a wide array of technical skills across biology, chemistry and biotechnology, and has successfully translated business strategies into R&D strategies throughout a range of leadership positions. In her most recent executive role as Chief Innovation Officer at DSM, she was responsible for accelerating innovation across the company and focused on valorizing science. Previously, Ms. Malarkey had a long tenure at Syngenta across a variety of technology roles, culminating in her serving as Head, Research and Development and a member of the Syngenta Executive Committee. She is a non-executive director and innovation advisor to a number of established and start up Food and AgTech organizations. On the Meatable Board, Ms. Malarkey will help guide and support the management team in delivering its scientific, technological, regulatory and marketing goals to the US market. Malarkey earned her Master of Science, Toxicology from the University of Surrey and her Bachelor’s degree from the University of Glasgow.

“Meatable is working at the forefront of food technology and is a clear-cut leader in the cultivated meat space,” said Malarkey. “I firmly believe in Meatable’s mission to mitigate the environmental impact of meat production and address concerns in animal welfare, food security and human health. I look forward to leveraging my expertise in innovation efforts and scaling sustainable food companies to help the Meatable team continue to build upon its core technological advantages and expand into the US market and beyond.”

In addition to Abony and Malarkey, the Meatable’s Board of Directors is comprised of highly experienced food and technology executives in both the USA and European markets. Led by Chairman of the Board Cees de Jong, Chairman of Novonesis (recent merger of Novozymes and Chr. Hansen) and former President and CEO of Chr. Hansen, the Board of Directors includes Anthony Chow, co-founder of Agronomics Limited and an early investor in the company, Jason Whitmire, General Partner at BlueYard Capital and the lead investor in Meatable’s seed investment round, and co-founders de Nood and Daan Luining, CTO of Meatable.

If you have any questions or would like to get in touch with us, please email info@futureofproteinproduction.com

About the Speaker

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Every week, you’ll receive a compilation of the latest breakthroughs from the global alternative proteins sector, covering plant-based, fermentation-derived and cultivated proteins.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.